PEP rises 7% to £1,076k after flatlining in FY23 | 2d
PEP rises 7% to £1,076k after flatlining in FY23 | 2d
Pan-European patent court delivers first revocation judgment a year and a month after opening | 1w
Trio of partners join from Wilson Sonsini and boutique Hooper Lundy & Bookman as Orrick continues life sciences push | 2w
Raleigh office will target healthcare work and is top 50 firm’s 23rd US base | 2w
This third edition provides answers and insight into how luxury businesses can protect their brands in a range of jurisdictions. | 1mo
Editors:
Glucose monitoring patent revoked across 17 UPC member states in ongoing dispute with rival Abbott | 2w
Freshfields, Taylor Wessing and Powell Gilbert advise on closely watched London High Court dispute | 3w
IP and disputes group’s move follows ArentFox Schiff adding automotive partner quartet from Burns in Boston in April | 1mo
Team moves over from Lerner David strengthening medical device practice | 1mo
Decision upholds earlier ruling revoking patent covering the drug Xarelto, further clearing way for generic manufacturers to enter the lucrative market | 1mo
Tobias Knapp joins as co-head of global firm’s New York transactional group | 1mo
Covington counsels Biogen as Goodwin reps acquisition target Human Immunobiology Biosciences | 2mos
Former FDA lawyers Jennifer Bragg and William McConagha move over in DC as Safehold CLO Douglas Heitner joins real estate team in New York | 2mos
Office to handle outbound work for Japanese clients as UK firm aims to reach €1bn revenue in five years | 2mos
Led by respected life sciences litigator Siegmund Gutman, the team of 10 move over from Proskauer Rose | 2mos
Düsseldorf local division orders US life sciences company Curio Bioscience to stop selling its products in Germany, France and Sweden in dispute with rival 10x Genomics | 2mos
Transatlantic merger creates global giant with nearly 4,000 lawyers and $3.5bn revenue | 2mos
UK pharmaceutical firm enters the fray in the battle over mRNA technology used to develop blockbuster vaccines | 2mos
Greenberg counsels Ono in deal to expand Japanese group’s oncology portfolio and US presence | 2mos
Women make up majority of round for firm in strong growth mode | 3mos
Irena Royzman is fourth IP partner to join tech-focused firm this year | 3mos